Ngeunaan Dokter
Dr Shigenobu Suzuki mangrupikeun spesialis kanker panon luhur di Tokyo, Jepang.
Dr Shigenobu Suzuki pakait sareng Rumah Sakit Pusat Kanker Nasional, Jepang.
The Department of Ocular Oncology is one of the rare groups specializing in ocular tumors, especially intraocular tumors. Recently, more than 70% of patients nationwide with retinoblastoma, which is the most frequent intraocular malignancy in childhood, and more than 50% of patients with choroidal melanoma, which is the most frequent primary intraocular malignancy in adults, have been referred to our department. We also treat ocular adnexal tumors. More than 350 operations have been done annually.
Kami milu dina uji klinis ku estimasi kajadian ngarugikeun ocular tina kémoterapi sistemik. Terapi target molekular panganyarna kadang ngabalukarkeun busung lapar macular, detachment rétina serous, uveitis, kasakit permukaan ocular, jeung saterusna, sarta kami evaluate sarta ngubaran ieu acara ngarugikeun nyumbangkeun percobaan klinis.
rumah sakit
Spésialisasi
- Onkologi Ophthalmic
Prosedur Dilaksanakeun
- Onkologi Ophthalmic
- retinoblastoma
- Édema macular
- Choroidal melanoma
